Latest news with #Kramm
Business Insider
09-07-2025
- Business
- Business Insider
UBS Reaffirms Their Buy Rating on Tradeweb Markets (TW)
In a report released today, Alex Kramm from UBS reiterated a Buy rating on Tradeweb Markets, with a price target of $155.00. The company's shares closed today at $134.74. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Kramm is a 5-star analyst with an average return of 11.7% and a 64.56% success rate. Kramm covers the Financial sector, focusing on stocks such as CME Group, Cboe Global Markets, and Intercontinental Exchange. In addition to UBS, Tradeweb Markets also received a Buy from Citi's Christopher Allen in a report issued yesterday. However, on the same day, Morgan Stanley maintained a Hold rating on Tradeweb Markets (NASDAQ: TW). TW market cap is currently $33.13B and has a P/E ratio of 57.55.
Yahoo
21-05-2025
- Business
- Yahoo
UBS Keeps Buy Rating on MSCI with $655 Price Target
On Wednesday, May 21, UBS reiterated a 'Buy' rating and a price target of $655 for MSCI Inc. (NYSE:MSCI). UBS analyst Alex Kramm shared insights from a recent investor meeting with the company's CFO, Andy Wiechmann. MSCI Inc.'s (NYSE:MSCI) management had a generally optimistic outlook. The discussion highlighted that the environment is getting better for the company, especially noting a shift in asset allocation. More investors are moving towards global markets and away from the US market. Despite the optimism, some market uncertainty was still acknowledged, which makes it difficult to predict exactly when the company's financial position will improve. A successful portfolio manager working on a laptop in a large office with a city view, representing the success of the company in the financial sector. Kramm noted that growing client confidence is a key driver for better performance ahead. MSCI Inc.'s (NYSE:MSCI) new projects are also expected to help the company grow. The company is focused on key areas like private assets and climate-related products. The analyst is confident that MSCI Inc. (NYSE:MSCI) can reaccelerate its growth. However, Kramm also noted that investors may want to see clearer proof of the company's progress before fully committing to the stock. MSCI Inc. (NYSE:MSCI) is a leading provider of critical investment decision support tools and services. Serving the global investment community, the company specializes in research, data, and technology. It enables better investment decisions by helping clients understand and analyze key drivers of risk and return. While we acknowledge the potential of MSCI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MSCI and that has a 100x upside potential, check out our report about the cheapest AI stock. READ NEXT: 11 Stocks That Will Bounce Back According To Analysts and 11 Best Stocks Under $15 to Buy According to Hedge Funds. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
26-04-2025
- Business
- Business Insider
UBS Reaffirms Their Buy Rating on CME Group (CME)
UBS analyst Alex Kramm maintained a Buy rating on CME Group (CME – Research Report) yesterday and set a price target of $305.00. The company's shares closed yesterday at $266.30. Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. Kramm covers the Financial sector, focusing on stocks such as CME Group, Nasdaq, and Intercontinental Exchange. According to TipRanks, Kramm has an average return of 10.5% and a 62.15% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for CME Group with a $273.15 average price target, implying a 2.57% upside from current levels. In a report released on April 24, Piper Sandler also maintained a Buy rating on the stock with a $283.00 price target. CME market cap is currently $94.88B and has a P/E ratio of 26.47. Based on the recent corporate insider activity of 96 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CME in relation to earlier this year. Last month, William Shepard, a Director at CME bought 11.00 shares for a total of $2,888.82.
